Significant changes to the way European health technology assessments (HTA) take place is underway, with a transitional period set to be in force for several ye 18 September 2023
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended authorizing a version of BioNTech (Nasdaq: BNTX) and Pfizer’s (NYSE: PFE) 30 August 2023
The European Commission (EC) has approved the extension of the Evrysdi (risdiplam) European Union (EU) marketing authorization to include infants with a clinica 29 August 2023
New York-based pharma giant Pfizer (NYSE: PFE) has secured a European approval for Abrysvo, an innovative vaccine to prevent infection with respiratory syncytia 25 August 2023
As European drugmakers wrestle with regional lawmakers over proposed legislative changes, the industry has been emboldened by a German government report raising 11 August 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.